Trump Tariffs Could Be Coming For Pharma Companies Next. What Investors Need To Know. | IBD

Trump tariffs have rocked the stock market and are projected to increase prices for a whole host of consumer goods. Pharmaceuticals have been exempt from those duties so far. But Trump has indicated that the industry could face separate tariffs. IBD's biopharma and medtech reporter Allison Gatlin explains the latest developments.

Check out our daily newsletter! https://get.investors.com/marketdiem/

Get more IBD by subscribing to our channel:    / @investorsbusinessdaily  

Visit our website: https://www.investors.com
Like us on Facebook:   / investorsbusinessdaily  
Follow us on X: https://x.com/IBDinvestors
Follow us on Instagram:   / investorsbusinessdaily  
Follow us on StockTwits: https://stocktwits.com/InvestorsBusin...
Follow us on LinkedIn:   / investors-business-daily  
Follow us on TikTok:   / ibdinvestors  

Investor’s Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.

#InvestorsBusinessDaily #IBD